Last reviewed · How we verify
Blink® Tears eye drops
Blink® Tears eye drops is a artificial tears Small molecule drug developed by Johnson & Johnson Vision Care, Inc.. It is currently in Phase 2 development for Relief of dryness and irritation associated with dry eye syndrome.
Blink Tears eye drops lubricate the eyes to relieve dryness and irritation.
Blink Tears eye drops are used to treat dry eye, as indicated by ClinicalTrials.gov. The exact mechanism of Blink Tears eye drops is not specified in the provided facts, but ChEMBL suggests that they may contain ingredients that help lubricate the eyes.
-
Baseline phase 2 → approval rate
+15.3pp
Industry-wide phase 2 drugs reach approval ~15.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas). -
Big-pharma sponsor
+3.0pp
Johnson & Johnson Vision Care, Inc. is a top-20 pharma sponsor — historical approval rates run ~3pp above average due to scale, regulatory experience, and trial-design quality.
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2031–2034 | — |
| EMA | EU | 2032–2035 | +0.7 yr |
| MHRA | GB | 2032–2035 | +0.7 yr |
| Health Canada | CA | 2032–2036 | +0.9 yr |
| TGA | AU | 2032–2036 | +1.2 yr |
| PMDA | JP | 2032–2036 | +1.5 yr |
| NMPA | CN | 2033–2037 | +2.3 yr |
| MFDS | KR | 2032–2036 | +1.4 yr |
| CDSCO | IN | 2032–2037 | +1.8 yr |
| ANVISA | BR | 2033–2037 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | Blink® Tears eye drops |
|---|---|
| Sponsor | Johnson & Johnson Vision Care, Inc. |
| Drug class | artificial tears |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | Phase 2 |
Mechanism of action
Blink Tears eye drops work by forming a thin layer on the surface of the eye to help retain moisture and protect the eye from further irritation. This helps to relieve dryness and discomfort associated with dry eye syndrome.
Approved indications
- Relief of dryness and irritation associated with dry eye syndrome
Common side effects
- Eye irritation
Key clinical trials
- Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of Investigational Lubricating Eye Drops (PHASE2)
- Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients (PHASE2)
- Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of a Lipid- Based Lubricating Eye Drop (PHASE1)
- Clinical Evaluation of an Investigational Lipid Drop in Non-contact Lens Wearing Patients
- Clinical Evaluation of Two Marketed Artificial Tears in Non-contact Lens Wearing Patients (PHASE4)
- Efficacy and Safety Study of FID 119515A (NA)
- A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular Lens (PHASE4)
- Efficacy and Acceptability of Two Lubricant Eye Drops (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Blink® Tears eye drops CI brief — competitive landscape report
- Blink® Tears eye drops updates RSS · CI watch RSS
- Johnson & Johnson Vision Care, Inc. portfolio CI
Frequently asked questions about Blink® Tears eye drops
What is Blink® Tears eye drops?
How does Blink® Tears eye drops work?
What is Blink® Tears eye drops used for?
Who makes Blink® Tears eye drops?
What drug class is Blink® Tears eye drops in?
What development phase is Blink® Tears eye drops in?
What are the side effects of Blink® Tears eye drops?
Related
- Drug class: All artificial tears drugs
- Manufacturer: Johnson & Johnson Vision Care, Inc. — full pipeline
- Therapeutic area: All drugs in Ophthalmology
- Indication: Drugs for Relief of dryness and irritation associated with dry eye syndrome
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing